Category Archives: Stem Cell Videos

CLEVELAND, Ohio-- Imagine cooking up a new recipe for carrot cake and trying to figure out what it tastes like by feeding it to your dog. You might be able to learn something from his reactions -- Does he eat some? A lot? Does he, heaven forbid, keel over afterward? -- but you'd be pretty limited by some basic differences between you and your canine friend. Even if he could somehow tell you what he thinks, there's just no telling if cake tastes the same to a dog.

This is something like the problem faced by researchers who are trying to understand and treat devastating human brain diseases like Parkinson's and Huntington's by working with mice.

The mouse brain has told us a lot about the diseases, but, in the end, it's only a stand-in for working with the real thing.

Now the real thing is here. Two groups of Parkinson's and Huntington's researchers working in 13 labs nationwide have used advanced stem-cell technology to make human brain cells from skin cells donated by patients with those diseases. The brain cells look and act like cells affected by the diseases, and they can be manipulated in a petri dish.

Working with the new cells in a petri dish is a little like taking a bite of your recipe and getting your own reaction, without the potential of making yourself sick.

It's a first for the field, says Dr. Christopher Ross, one of the Huntington's disease study's lead researchers and professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine in Baltimore.

"It's going to be a tremendous opportunity to study the disease, to understand it, and particularly to develop therapeutics," he says.

Huntington's disease is inherited and caused by a defect in a single gene. The disease is progressive and fatal, causing twitching and jerking movement, dementia and brain-cell death. It affects about 30,000 people in the United States. Parkinson's, while not fatal, affects about 1 million Americans and causes progressively worsening movement problems as well as mood and sleep disruptions.

The technology that made the recent advance possible, called induced pluripotent stem cells, or iPSCs, was developed about four years ago simultaneously at the University of Wisconsin and in Japan.

In short, iPSCs are adult cells (usually skin or blood cells) taken from a donor with the disease and then genetically reprogrammed, or induced, back to their most primitive state. Once they are turned into stem cells, they can be forced to develop into any cell in the human body.

Originally posted here:
Parkinson's, Huntington's disease research makes advances with stem cells: Discoveries

Public release date: 23-Jul-2012 [ | E-mail | Share ]

Contact: Yivsam Azgad news@weizmann.ac.il 972-893-43856 Weizmann Institute of Science

Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link.

The scientists managed to uncover the details of a step in the process of DNA "repackaging" that takes place during embryonic stem cell differentiation. It turns out that for the cells to differentiate properly, certain pieces of the packaging of their DNA must be labeled by a molecular tag called ubiquitin. Such tagging is required for turning on a group of particularly long genes, which enable the stem cell to differentiate. The researchers identified two switches: An enzyme called RNF20 enhances the tagging, whereas a second enzyme, USP44, does the opposite, shutting it down. Furthermore, it appears that both these switches must operate properly for the differentiation process to proceed efficiently. When the scientists interfered with the tagging either by disabling the "ON" switch RNF20, or by deregulating the activity of the "OFF" switch USP44 the stem cells failed to differentiate.

These experiments might explain the significance of molecular defects identified in a number of cancers, for example, the abnormally low levels of RNF20 in certain breast and prostate cancers and the excess of USP44 in certain leukemias. Notably, faulty differentiation of stem cells is often a hallmark of the more aggressive forms of cancer. This research was led by Prof. Moshe Oren of the Molecular Cell Biology Department, with Prof. Eytan Domany of the Physics of Complex Systems Department and Dr. Jacob Hanna of the Molecular Genetics Department. The team included Weizmann Institute's Gilad Fuchs, Efrat Shema, Rita Vesterman, Eran Kotler, Sylvia Wilder, Lior Golomb, Ariel Pribluda and Ester Feldmesser, as well as Zohar Wolchinsky of the Technion Israel Institute of Technology, Feng Zhang and Xiaochun Yu of the University of Michigan in the US, Mahmood Haj-Yahya and Ashraf Brik of Ben-Gurion University of the Negev, and Daniel Aberdam of the Technion and the University of Nice-Sophia Antipolis in France.

This study belongs to a relatively new direction in cancer research: Rather than focusing on the genes involved, it highlights the role of epigenetics that is, processes that do not modify the gene code, itself, but affect the way its information is interpreted within the cell. Understanding the epigenetic roots of cancer will advance the search for effective therapies for this disease.

###

Prof. Eytan Domany's research is supported by the Kahn Family Research Center for Systems Biology of the Human Cell, which he heads; the Mario Negri Institute for Pharmacological Research - Weizmann Institute of Science Exchange Program; the Leir Charitable Foundations; and Mordechai Segal, Israel. Prof. Domany is the incumbent of the Henry J. Leir Professorial Chair.

Dr. Jacob Hanna's research is supported by the Leona M. and Harry B. Helmsley Charitable Trust; Pascal and Ilana Mantoux, France/Israel; the Sir Charles Clore Research Prize; Erica A. Drake and Robert Drake; and the European Research Council.

Prof. Moshe Oren's research is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; the Robert Bosch Foundation; the estate of Harold Z. Novak; and the European Research Council. Prof. Oren is the incumbent of the Andre Lwoff Professorial Chair in Molecular Biology.

Visit link:
Judging DNA by its cover

Study Highlights :

Embargoed until: 4 p.m. CT/5 p.m. ET Monday, July 23, 2012

NEW ORLEANS, July 23, 2012 (GLOBE NEWSWIRE) -- Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions.

The study is simultaneously published in the Journal of the American College of Cardiology.

The research could one day lead to new treatments for heart failure patients, researchers said.

"Since patients with heart failure are normally elderly, their cardiac stem cells aren't very healthy," said Sadia Mohsin, Ph.D., one of the study authors and a post-doctoral research scholar at San Diego State University's Heart Institute in San Diego, Cal. "We modified these biopsied stem cells and made them healthier. It is like turning back the clock so these cells can thrive again."

Modified human stem cells helped the signaling and structure of the heart cells, which were biopsied from elderly patients. Researchers modified the stem cells in the laboratory with PIM-1, a protein that promotes cell survival and growth.

Cells were rejuvenated when the modified stem cells enhanced activity of an enzyme called telomerase, which elongates telomere length. Telomeres are "caps" on the ends of chromosomes that facilitate cell replication. Aging and disease results when telomeres break off.

"There is no doubt that stem cells can be used to counter the aging process of cardiac cells caused by telomere degradation," Mohsin said.

The technique increased telomere length and activity, as well as increasing cardiac stem cell proliferation, all vital steps in combating heart failure.

Read the rest here:
Aging Heart Cells Rejuvenated by Modified Stem Cells

MOBILE, Alabama -- Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented today at the American Heart Associations Basic Cardiovascular Sciences 2012 Scientific Sessions in New Orleans.

The study is simultaneously published in the Journal of the American College of Cardiology. The stem cell research could lead to new treatments for heart failure patients, researchers said.

Since patients with heart failure are normally elderly, their cardiac stem cells arent very healthy, said Sadia Mohsin, Ph.D., one of the study authors and a post-doctoral research scholar at San Diego State Universitys Heart Institute in San Diego.

We modified these biopsied stem cells and made them healthier. It is like turning back the clock so these cells can thrive again.

Modified human stem cells helped the signaling and structure of the heart cells, which were biopsied from elderly patients, according to information provided by the American Heart Association.

Researchers modified the stem cells in the laboratory with PIM-1, a protein that promotes cell survival and growth. Cells were rejuvenated when the modified stem cells enhanced activity of an enzyme called telomerase, which elongates telomere length.

Telomeres are caps on the ends of chromosomes that aid cell replication. Aging and disease results when telomeres break off.

There is no doubt that stem cells can be used to counter the aging process of cardiac cells caused by telomere degradation, Mohsin said in a statement.

The technique increased telomere length and activity, as well as increasing cardiac stem cell proliferation, all vital steps in combating heart failure, health officials have said.

While human cells were used, the research was limited to the laboratory. Researchers have tested the technique in mice and pigs and found that telomere lengthening leads to new heart tissue growth in about four weeks.

Originally posted here:
Stem cells used to rejuvenate damaged heart tissue, study shows

New cells to replace those destroyed in diabetes type 1, cells to help heal a heart attack, cells to cure leukemia this is the promise of stem cells. Some of this is happening now; more will be available in a few years. Stem cells will usher in the era of regenerative medicine, allowing the creation of cells, tissues and organs to treat or cure diseases and injuries. This will be a fundamental alteration in our approach to medical care and a transformational medical megatrend. And it will be very personalized medicine to provide the specific individual with custom tailored new cells and tissues for organ repair or replacement. Extensive use of stem cells as therapy is still in its infancy. Call it infancy because there is so much basic science still to be understood, that it will be quite some years before we will see stem cells being used on any sort of regular basis to treat diabetes, Parkinsons disease, or heart failure after a heart attack. But time flies, many investigators are hard at work and the science may advance quickly. There are exceptions; stem cells are being actively used for a few situations and have been for many years. Among them are bone marrow or stem cell transplantation for diseases like leukemia, some cancers being treated with very high doses of chemotherapy or some individuals, especially children, with immune disorders. Since stem cells have the potential to be of ever increasing importance to medical care, albeit not for a few years, it is important to understand just what a stem cell is, generally how the various types of stem cells differ from each other and how they are either found in the body or produced in the laboratory. The key characteristics of stem cells are that 1) they can replicate themselves and 2) they can become mature cells that make up the tissue and organs of the body. Embryonic stem cells are found in the earliest divisions of the fertilized ovum and can become any of the bodys approximately 200 types of cells (liver, lung, brain) and they have the capacity when placed in tissue culture in the laboratory to divide and to replicate themselves indefinitely. We call them pluripotent in that they can become any of the various types of cells in the body. Think of them as the most fundamental cellular building block that can create the tissues and organs of our body. Adult stem cells, as the name implies, can be found in the bodies of adults (or newborns and children for that matter.) They also can self replicate but when placed in tissue culture it has not been possible to have them replicate indefinitely as embryonic stem cells do. Adult stem cells generally only can differentiate into one type of the bodys cells or tissue, i.e., are unipotent. For example muscle stem cells only become muscle cells but not liver cells. But some adult stem cells, such as those from the bone marrow, can become multiple but not all types of cells. Stem cells obtained from the umbilical cord of a newborn baby are more like adult stem cells in that they can develop into some but apparently not all cells types. In effect, they are further along in the chain of differentiation.

There are also other types of stem cells that as of now are being produced in the laboratory and which have many of the attributes of embryonic stem cells nuclear transfer, induced pluripotent, and protein-induced pluripotent stem cells, among others. To create the nuclear transfer stem cell, an unfertilized egg is obtained from a womans ovary. The egg has its nucleus extracted by a micropipette and then has the nucleus of an adult cell inserted in its place. This nucleus might be obtained from a skin cell taken from the arm of a patient with a particular problem such as diabetes. The newly created cell is placed in culture and with the appropriate signals begins to act like an embryonic stem cell in that it will divide and replicate itself and with the appropriate signals the daughter cells can become various body cell types. The hope is that these cells, genetically identical to the patient who had the skin biopsy, could be grown up into a vast number of in this example pancreatic islet cells and used to treat this individual patients diabetes.

The induced pluripotent stem cell (or iPSC) also has many of the embryonic stem cells characteristics. It is produced by taking a persons cells such as from the skin of the arm and then stimulating them by inserting a few key genes, using a retrovirus. These genes reprogram the cell to revert to what is similar to an embryonic stem cell. The concern of course is that it is induced using a virus. More recent experiments have found that certain proteins can reprogram the cell just as can the virally-inserted genes. These stem cells are known as protein-induced pluripotent stem cells (piPSC). Both are being evaluated to determine if they can be as effective as embryonic stem cells. With each of these three techniques, a clear hoped for advantage is that a person can donate his or her own cells for transformation into stem cells and from there into whatever cell is of interest, such as pancreatic islet cells that secrete insulin. Such cells transplanted back into the person would be recognized as self and not trigger rejection with a graft vs. host response by the body. This concept with each technique is therefore all about personalized medicine.

Next time I will delve more deeply into adult stem cells followed the next time by embryonic stem cells. But in the meanwhile think of stem cell science as one more of those truly transformative medical megatrends that will revolutionize the practice of medicine in the years to come and in the process improve the healthcare of you and your family.

View post:
Medical Megatrends — Stem Cells — Part I of III

By Stephanie Condron and Jo Macfarlane

PUBLISHED: 16:11 EST, 21 July 2012 | UPDATED: 16:11 EST, 21 July 2012

An urgent inquiry has been launched after The Mail on Sunday discovered dentists are being offered cash incentives to remove healthy milk teeth from children to harvest stem cells.

Hundreds of dentists are preparing to offer parents the 1,300 service, marketed as a way to protect against future diseases because stem cells can turn into any kind of cell and help repair damaged tissue.

Dentists will be rewarded with a cash bonus of 100 for each patient who supplies a tooth to be processed.

Precious Cells' founder Husein Salem tweeted this picture of him (centre) with reality TV stars Chantelle Houghton, left, and Alex Reid, right

There is no evidence as yet that dental stem cells can be used for medical purposes but research is ongoing.

And last night critics said healthy teeth should never be removed unless for dental reasons. It appears that any other removal could breach strict standards set down by the General Dental Council.

The GDC rules state dentists must put patients interests before their own or those of any organisation or business.

Continue reading here:
Dentists' macabre scheme to extract children's healthy milk teeth for stem cells by offering a £100 bonus for each one ...

Its fairly widely known that stem cells can mean life-saving treatments for deadly diseases.

Now, they are being used in the fight against wrinkles and more and more South Floridians are turning to the stem cell makeover.

Donna Pritchit is one of them. The 64-year-old headed into the operating room recently, wanting to turn back the hands of time without it being totally obvious.

I dont want someone to stop and go by and say Oh, she had a facelift. I want to have someone say Donna went on vacation she must be having a great life, she said before the $5,000 procedure began.

Dr. Sharon McQuillan at the Ageless Institute in Aventura marked the areas where she would take fat out of Pritchits belly and place it back into her face.

The retired teacher also hoped it would be her last step in getting rid of embarrassing acne scars.

I never wanted to go out in daylight and have anyone see me, she said.

More South Florida Health News

The outpatient procedure began with traditional liposuction, and then McQuillan and her team processed that fat and concentrated the stem cells so they could be injected into Pritchits wrinkles and in places where she has lost fullness.

Well, stem cells in general are the cells in your body that regenerate tissue and heal tissue, and they make the skin look beautiful and younger, McQuillan explained. And they also the fat to remain alive so that the volume that we create stays, which has been a problem with fat transfer in the past.

See the original post:
More South Floridians Trying "Stem Cell Makeover"

Connie K. Ho for redOrbit.com Your Universe Online

20,000,000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy with intramuscular delivery.

To begin, Pluristem uses stem cells from the human placenta and has created a manufacturing process that produces enough cells to treat 10,000 patients from one placenta.

You usually have to match cells to donors so they do not react. Placental cells are unique because they come from a unique section that combines the mother and the baby. They can be injected without no question age or sex, remarked Zami Aberman, Chairman and CEO of Pluristem.

PLacental eXpanded, otherwise known as PLX, cells release a mix of therapeutic proteins to target local and systemic inflammatory diseases. The cells are developed with 3D micro-environmental technology that doesnt require tissue matching before administration. Unlike other cell therapies that are conducted with intravenous injections, the Pluristem treatment includes intramuscular injections that are injected with a needle into the muscle.

The cells are grown in 3D and not in human. With [this] technology we give them more natural place, grown in better way, produced in an efficient way to become an official product, stated Aberman.

Researchers believe that intravenous treatments will allow them to have a greater variety of possible outpatient settings and local clinics.

The ability for IM injections of PLX cells has significant market implications that potentially broaden the indications and frequency with which our cell therapy can be used. We look forward to conducting additional testing of this very promising approach, commented Aberman in a prepared statement.

The company recently received clearance from the U.S. Food and Drug Administration (FDA) to begin Phase II clinical trial for the PLX-PAD cells, which can treat a type of peripheral artery disease known as Intermittent Claudication (IC),which causes pain when walking.

One thing to mention about the study is it is the first time given to patients with other options, noted Aberman. Its important to mention as the FDA recognized that the safety profile of the PLX in phase one was good and promising enough to move to patients who are in less severe conditions.

See more here:
Pluristem Focuses On Therapeutic Cells Delivered Intramuscularly

(PRWEB) July 21, 2012

[Olez INCEPTION is the first hair straightening product line to take advantage of apple stem cells excellent strengthening and anti-aging properties.

Apple stem cells from a rare Swiss apple, called the Uttwiler Sptlauber, are rich in hydrogen, phytonutrients, antioxidants, proteins and age resistant cells. These apple stem cells are being utilized for the first time within a hair straightening product line. It makes perfect sense, since the stem cells have excellent strengthening and anti-aging properties that enhance the longevity of the hair follicles and protect the hairs own stem cells. Currently, apple stem cells are the most exciting breakthrough ingredient within the cosmetics industry.

Olez INCEPTION is the first professional hair system to incorporate the use of Apple Stem Cell technology along with the finest natural ingredients. Apple stem cells slow down the deterioration of hair follicles, allowing INCEPTIONs straight and shiny results to last for up to 6 months, something other straightening brands have not been able to achieve. Olez INCEPTION provides a unique Naturally Straight look; in contrast to the processed look other treatments offer.

Everything needed for beautiful and healthy hair and to create a wow! factor comes in Olez INCEPTIONs convenient 4 product kit: Cleansing and Nourishing Shampoo, Action Apple Stem Cell Solution, Sealer and Stem Cell Masque.

Leading industry lab faculty, Kosmo Science Laboratories, performed months of testing on the product. A stress test conducted on curly hair simulated the successful longevity of the treatment beyond 6 months.

Olez INCEPTIONs product line includes two home care products:

INCEPTION Stem Cell Masque utilizes stem cells from the rare Uttwiler Sptlauber apple as well as the finest of natural ingredients including Muru-Muru, Cupuau and Carite butters for incredibly sleek, silky, soft hair.

INCEPTION Argan & Pracaxi Natural Oil Spray comes in an eco friendly aerosol that dispenses the unique formula, a blend of Argan and Pracaxi natural oils. It hydrates and conditions, while protecting the hair with antioxidants. The Spray is also effective in combating the damaging effects of UV rays while maintaining silky, shiny, and smooth hair.

Salons have a unique opportunity to carry the Olez INCEPTION line, thereby providing a treatment to their clients that features breakthrough technology and provides significant profit potential.

More:
Can Apple Stem Cells Give Women Straight Hair?

Public release date: 19-Jul-2012 [ | E-mail | Share ]

Contact: Anne Rahilly arahilly@unimelb.edu.au 61-390-355-380 University of Melbourne

The study, published in the journal Stem Cell, adds to our understanding of the role of stem and next stage progenitor cells in tissue regeneration and in the diagnosis and treatment of cancer.

While stem cells are known to reside in organs such as the liver and pancreas, they are difficult to isolate. The new findings show that an antibody developed by the team can be used to capture the stem cells.

Professor Pera, program leader for Stem Cells Australia and Chair of Stem Cell Sciences at the University of Melbourne, said the antibody was able to detect progenitor cells in disease states such as cirrhosis of the liver, and in cancers such as pancreatic adenocarcinoma and oesophageal carcinoma.

"By being able to identify these cells, we hope to be able to learn more about their role in tissue regeneration and in cancer especially in the diagnosis and treatment of pancreatic cancer," he said.

"Cancers of the liver, pancreas and oesophagus are often very difficult to detect and challenging to treat."

The large collaboration of scientists from around the world working on this study evolved over many years with research undertaken in Professor Pera's laboratories at the then Australian Stem Cell Centre and at the University of Southern California.

Professor Pera and one of the co-authors on the paper, Dr Kouichi Hasegawa, were recently awarded an Australia-India Strategic Research Fund grant to continue their search for novel markers for liver, pancreatic and gut stem cells. Dr Hasegawa, who recently undertook a three month sabbatical at Stem Cells Australia, holds positions at Kyoto University's Institute for Integrated Cell-Materials Sciences and at the Institute for Stem Cell Biology and Regenerative Medicine at the National Centre for Biological Sciences in Bangalore, India.

"This funding will support us to develop more antibodies that can be used to assist in the identification and prospective isolation of stem and progenitor cells in these tissues and lead to the development of novel diagnostic and therapeutic reagents." Said Professor Pera.

More here:
Stem cell research aids understanding of cancer